Biological assay and liquid chromatographic method for analysis of moxifloxacin in tabletsGUERRA, Fanny L. B; PAIM, Clesio S; STEPPE, Martin et al.Journal of AOAC International. 2005, Vol 88, Num 4, pp 1086-1092, issn 1060-3271, 7 p.Article

Penetration of Moxifloxacin into Bone Evaluated by Monte Carlo SimulationLANDERSDORFER, Cornelia B; KINZIG, Martina; HENNIG, Friedrich F et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 2074-2081, issn 0066-4804, 8 p.Article

The Effect of Moxifloxacin on QTc and Implications for the Design of Thorough QT StudiesBLOOMFIELD, D. M; KOST, J. T; GHOSH, K et al.Clinical pharmacology and therapeutics. 2008, Vol 84, Num 4, pp 475-480, issn 0009-9236, 6 p.Article

Protonation equilibrium and lipophilicity of moxifloxacinLANGLOIS, Marie-Hélène; MONTAGUT, Martine; DUBOST, Jean-Pierre et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 2, pp 389-393, issn 0731-7085, 5 p.Article

Detection of resistance to gatifloxacin and moxifloxacin in Streptococcus pneumoniae with the VITEK 2 instrumentJORGENSEN, J. H; CRAWFORD, S. A; MCELMEEL, L. M et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 12, pp 5928-5930, issn 0095-1137, 3 p.Article

Moxifloxacin Retains Antimycobacterial Activity in the Presence of gyrA MutationsMCGRATH, Marieta; VAN PITTIUS, Nico C. Gey; SIRGEL, Frederick A et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 5, pp 2912-2915, issn 0066-4804, 4 p.Article

Determination of Moxifloxacin and its Oxidation Products with Kinetic Evaluation Under Potassium Permanganate Treatment in Acidic Solution by Ultra-Performance Liquid Chromatography/Tandem Mass SpectrometryHUBICKA, Urszula; ZMUDZKI, Paweł; ZAJDEL, Paweł et al.Journal of AOAC International. 2013, Vol 96, Num 6, pp 1288-1294, issn 1060-3271, 7 p.Article

Moxifloxacin Punctum Plug for Sustained Drug DeliveryCHEE, Soon-Phaik.Journal of ocular pharmacology and therapeutics. 2012, Vol 28, Num 4, pp 340-349, issn 1080-7683, 10 p.Article

Mutant prevention concentrations of ABT-492, levofloxacin, moxifloxacin, and gatifloxacin against three common respiratory pathogensHERMSEN, Elizabeth D; HOVDE, Laurie B; KONSTANTINIDES, George N et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 4, pp 1633-1635, issn 0066-4804, 3 p.Article

Changing patterns of fluoroquinolone resistance among Bacteroides fragilis group organisms over a 6-year period (1997-2002)BETRIU, Carmen; RODRIGUEZ-AVIAL, Iciar; GOMEZ, Maria et al.Diagnostic microbiology and infectious disease. 2005, Vol 53, Num 3, pp 221-223, issn 0732-8893, 3 p.Article

Influence of efflux transporters on the accumulation and efflux of four quinolones (ciprofloxacin, levofloxacin, garenoxacin, and moxifloxacin) in J774 macrophagesMICHOT, Jean-Michel; SERAL, Cristina; VAN BAMBEKE, Francoise et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 6, pp 2429-2437, issn 0066-4804, 9 p.Article

Moxifloxacin penetration into human gastrointestinal tissuesWIRTZ, Martin; KLEEFF, Jörg; SWOBODA, Stefanie et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 53, Num 5, pp 875-877, issn 0305-7453, 3 p.Article

Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltrationFUHRMANN, Valentin; SCHENK, Peter; JAEGER, Walter et al.Journal of antimicrobial chemotherapy (Print). 2004, Vol 54, Num 4, pp 780-784, issn 0305-7453, 5 p.Article

Antibacterial activity of moxifloxacin on bacteria associated with periodontitis within a biofilmTSAOUSOGLOU, Phoebus; NIETZSCHE, Sandor; CACHOVAN, Georg et al.Journal of medical microbiology. 2014, Vol 63, Num 2, pp 284-292, issn 0022-2615, 9 p.Article

Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/ pharmacodynamic model employing pure and mixed culturesSCHAUMANN, Reiner; GOLDSTEIN, Ellie J. C; FORBERG, Jochen et al.Journal of medical microbiology. 2005, Vol 54, Num 8, pp 749-753, issn 0022-2615, 5 p.Article

Pharmacodynamics of moxifloxacin against anaerobes studied in an in vitro pharmacokinetic modelNOEL, Alan R; BOWKER, Karen E; MACGOWAN, Alasdair P et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 10, pp 4234-4239, issn 0066-4804, 6 p.Article

In vitro activity of moxifloxacin against community respiratory pathogens in QatarSITTANA SHAMSELDIN ELSHAFIE; AL-KUWARI, Jameela.International journal of antimicrobial agents. 2004, Vol 24, Num 3, pp 309-310, issn 0924-8579, 2 p.Article

Impact of Electrocardiographic Data Quality on Moxifloxacin Response in Thorough QT/QTc StudiesJOHANNESEN, Lars; GARNETT, Christine; MALIK, Marek et al.Drug safety. 2014, Vol 37, Num 3, pp 183-189, issn 0114-5916, 7 p.Article

Moxifloxacin-Induced Immune-Mediated Thrombocytopenia in a Chronic Kidney Disease Patient Receiving HemodialysisMAILMAN, Jonathan F; STIGANT, Caroline; MARTINUSEN, Dan et al.The Annals of pharmacotherapy. 2014, Vol 48, Num 7, pp 919-922, issn 1060-0280, 4 p.Article

Treatment outcomes and moxifloxacin susceptibility in ofloxacin-resistant multidrug-resistant tuberculosisJO, K.-W; LEE, S.-D; KIM, W. S et al.The International journal of tuberculosis and lung disease. 2014, Vol 18, Num 1, pp 39-43, issn 1027-3719, 5 p.Article

High-Dose Rifapentine with Moxifloxacin for Pulmonary TuberculosisJINDANI, Amina; HARRISON, Thomas S; MUNGOFA, Stanley et al.The New England journal of medicine. 2014, Vol 371, Num 17, pp 1599-1608, issn 0028-4793, 10 p.Article

Comparison of Levofloxacin versus Moxifloxacin for Multidrug-Resistant TuberculosisKOH, Won-Jung; SEUNG HEON LEE; SANG BONG CHOI et al.American journal of respiratory and critical care medicine. 2013, Vol 188, Num 7, pp 858-864, issn 1073-449X, 7 p.Article

Moxifloxacin for Buruli ulcer/HIV coinfected patients: kill two birds with one stone?O'BRIEN, Daniel P; COMTE, Eric; FORD, Nathan et al.AIDS (London). 2013, Vol 27, Num 14, pp 2177-2179, issn 0269-9370, 3 p.Article

Risk of Severe Dysglycemia Among Diabetic Patients Receiving Levofloxacin, Ciprofloxacin, or Moxifloxacin in TaiwanCHOU, Hsu-Wen; WANG, Jiun-Ling; CHANG, Chia-Hsuin et al.Clinical infectious diseases. 2013, Vol 57, Num 7, pp 971-980, issn 1058-4838, 10 p.Article

A single-dose placebo- and moxifloxacin-controlled study of the effects of temsirolimus on cardiac repolarization in healthy adultsBONI, Joseph P; LEISTER, Cathie; HUG, Bruce et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 6, pp 1433-1442, issn 0344-5704, 10 p.Article